Evaluation of a new B 2  adrenergic receptor stimulant, terbutaline, in bronchial asthma. I. Subcutaneous comparison with epinephrine.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002082:Butylamines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004837:Epinephrine / Q000008:administration & dosage* / Q000494:pharmacology; D004983:Ethanolamines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D010919:Placebos; D012118:Resorcinols / Q000627:therapeutic use; D012129:Respiratory Function Tests; D013147:Spirometry
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D002082:Butylamines; D004983:Ethanolamines; D010919:Placebos; D012118:Resorcinols; D004837:Epinephrine